The$S&P/ASX 200 (.XJO.AU)$closed 0.7% higher at 7,821.8 on Thursday, driven by broad-based gains across the index. The benchmark remained in positive territory throughout the day, following Canada's central bank's decision to cut interest rates, which raised hopes of looser monetary policy in other countries. Soft domestic economic growth data released on Wednesday had already eased concerns about possible rate hikes in Australia.
Australia's Trade Surplus Exceeds Expectations in April Amid Declining Imports
Australia's trade surplus expanded more than anticipated in April, driven by a significant decline in imports that outweighed a drop in key commodity exports. The trade surplus reached A$6.55 billion ($4.34 billion), according to data released by the Australian Bureau of Statistics on Thursday. This figure surpassed the expected surplus of A$5.37 billion and the previous month's revised balance of A$4.84 billion.
Telix Pharmaceuticals Launches $200 Million US IPO
$Telix Pharmaceuticals Ltd (TLX.AU)$has initiated its $200 million initial public offering on the Nasdaq, as per a Thursday filing with the Australian Stock Exchange. The company plans to provide underwriters with a 30-day over-allotment option, allowing them to purchase up to an additional 15% of the American Depositary Shares sold in the offering, according to the filing.
Source: Dow Jones Newswires, AFR, ASX
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more